Status:
NOT_YET_RECRUITING
Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric Cancer
Lead Sponsor:
The Affiliated Hospital of Qingdao University
Conditions:
Stomach Neoplasms
Neoadjuvant Therapy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study evaluates whether a family-supervised exercise-nutrition-psychology program can reduce complications after stomach-cancer surgery. Eligible patients are adults who will receive chemotherapy...
Eligibility Criteria
Inclusion
- Age 18-80 years
- Histologically proven gastric adenocarcinoma by gastroscopy
- Clinical stage T2-4a, N any, M0 planned for neoadjuvant chemotherapy plus radical gastrectomy
- ECOG performance status 0-1; ASA class I-III
- Able to understand the study and provide signed informed consent
Exclusion
- Previous or concurrent malignancies
- Emergent conditions (bleeding, perforation, obstruction) requiring immediate surgery
- Pregnant or lactating women
- Severe psychiatric disorders
- Prior major abdominal surgery (except laparoscopic cholecystectomy)
- Unstable angina, myocardial infarction, or cerebrovascular event within 6 months
- Continuous use of NSAIDs, corticosteroids, or probiotics within 1 month
- Simultaneous surgery for other diseases
- FEV1 \< 50 % predicted
- Any condition that, in the investigator's opinion, contraindicates participation
Key Trial Info
Start Date :
September 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 20 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07183358
Start Date
September 20 2025
End Date
June 20 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qingdao University Affiliated Hospital
Qingdao, Shandong, China, 266003